Acceleron Appoints Kevin McLaughlin as CFO

Acceleron Pharma, a biopharmaceutical company, has appointed Kevin McLaughlin as senior vice president (SVP) and chief financial officer (CFO). McLaughlin has more than 30 years of financial and operating management experience spanning the biotech, high tech and education industries.

Most recently, he served as SVP and CFO of Qteros, a cellulosic biofuels company. From 1996 through 2007, he held several executive positions with Praecis Pharmaceuticals. He joined the company as its CFO, where he had responsibility for private financings, partnership financings, the company’s initial public offering (IPO) and subsequent secondary stock offerings. Later, McLaughlin became chief operating officer (COO), and then president and chief executive officer (CEO), as well as serving as a member of the board of directors. In this capacity he was responsible for negotiating the sale of the company to GlaxoSmithKline (GSK).

He began his career in senior financial roles at Prime Computer and Computervision Corporation. McLaughlin received a BS from Northeastern University and MBA from Babson College.


Related reading